Vascular pharmacology of acute lung injury and acute respiratory distress syndrome
- 1 November 2002
- journal article
- review article
- Published by Elsevier in Vascular Pharmacology
- Vol. 39 (4-5) , 247-256
- https://doi.org/10.1016/s1537-1891(03)00013-2
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndromeCritical Care Medicine, 2002
- Nebulized prostaycclin (PGI2) in acute respiratory distress syndrome: Impact of primary (pulmonary injury) and secondary (extrapulmonary injury) disease on gas exchange responseCritical Care Medicine, 2001
- Dexamethasone and pentastarch produce additive attenuation of ischaemia/reperfusion lung injuryClinical Science, 2000
- Inhaled Nitric Oxide Reduces Pulmonary Transvascular Albumin Flux in Patients with Acute Lung InjuryAnesthesiology, 1995
- Prostaglandin E1 and Nitroglycerin Reduce Pulmonary Capillary Pressure but Worsen Ventilation—Perfusion Distributions in Patients with Adult Respiratory Distress SyndromeAnesthesiology, 1989
- The Effect of Nitroprusside on Pulmonary Edema, Oxygen Exchange, and Blood Flow in Hydrochloric Acid AspirationAnesthesiology, 1987
- EFFECT OF INDOMETHACIN ON ARTERIAL OXYGENATION IN CRITICALLY ILL PATIENTS WITH SEVERE BACTERIAL PNEUMONIAThe Lancet, 1987
- Response of Extravascular Lung Water to Intraoperative FluidsAnnals of Surgery, 1983
- Role of Thromboxane and Prostacyclin in Pulmonary Vasomotor Changes after Endotoxin in DogsJournal of Clinical Investigation, 1981
- Albumin Treatment Following Major SurgeryActa Anaesthesiologica Scandinavica, 1981